메뉴 건너뛰기




Volumn 69, Issue 4, 2012, Pages 329-338

Impact of atrial fibrillation and oral anticoagulation on hospital costs and length of stay

Author keywords

Anticoagulants; Atrial fibrillation; Costs; Economics; Hospitals; Managed care systems; Warfarin

Indexed keywords

WARFARIN;

EID: 84857590037     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110203     Document Type: Article
Times cited : (14)

References (18)
  • 1
    • 71649105333 scopus 로고    scopus 로고
    • Increasing prevalence of atrial fibrillation and flutter in the United States
    • Naccarelli GV, Varker H, Lin J et al. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009; 104:1534-9.
    • (2009) Am J Cardiol , vol.104 , pp. 1534-1539
    • Naccarelli, G.V.1    Varker, H.2    Lin, J.3
  • 2
    • 4644309097 scopus 로고    scopus 로고
    • Antithrombotic therapy in atrial fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    • DOI 10.1378/chest.126.3-suppl.429S
    • Singer DE, Albers GW, Dalen JE et al. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(suppl 3):429S-456S. (Pubitemid 39302603)
    • (2004) Chest , vol.126 , Issue.3 SUPPL.
    • Singer, D.E.1    Albers, G.W.2    Dalen, J.E.3    Go, A.S.4    Halperin, J.L.5    Manning, W.J.6
  • 4
    • 45949109467 scopus 로고    scopus 로고
    • Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
    • DOI 10.1378/chest.08-0720
    • Albers GW, Amarenco P, Easton JD et al., for the American College of Chest Physicians. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008; 133(suppl 6):630S-669S. (Pubitemid 351892974)
    • (2008) Chest , vol.133 , Issue.6 SUPPL. 6
    • Albers, G.W.1    Amarenco, P.2    Easton, J.D.3    Sacco, R.L.4    Teal, P.5
  • 5
    • 79960075350 scopus 로고    scopus 로고
    • A pharmacoeconomic perspective on stroke prevention in atrial fibrillation
    • Fendrick AM. A pharmacoeconomic perspective on stroke prevention in atrial fibrillation. Am J Manag Care. 2010; 16(suppl 10):S284-90.
    • (2010) Am J Manag Care , vol.16 , Issue.SUPPL. 10
    • Fendrick, A.M.1
  • 6
    • 33748358147 scopus 로고    scopus 로고
    • Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States
    • DOI 10.1111/j.1524-4733.2006.00124.x
    • Coyne KS, Paramore C, Grandy S et al. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health. 2006; 9:348-56. (Pubitemid 44337788)
    • (2006) Value in Health , vol.9 , Issue.5 , pp. 348-356
    • Coyne, K.S.1    Paramore, C.2    Grandy, S.3    Mercader, M.4    Reynolds, M.5    Zimetbaum, P.6
  • 8
    • 33646468354 scopus 로고    scopus 로고
    • Effect of study setting on anticoagulation control: A systematic review and meta-regression
    • Van Walraven C, Jennings A, Oake N et al. Effect of study setting on anticoagulation control: a systematic review and meta-regression. Chest. 2006; 129:1155-66.
    • (2006) Chest , vol.129 , pp. 1155-1166
    • Van Walraven, C.1    Jennings, A.2    Oake, N.3
  • 9
    • 65449163045 scopus 로고    scopus 로고
    • Metaanalysis to assess the quality of warfarin control in atrial fibrillation patients in the United States
    • Baker WL, Cio DA, Sander SD et al. Metaanalysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm. 2009; 15:244-52.
    • (2009) J Manag Care Pharm , vol.15 , pp. 244-252
    • Baker, W.L.1    Cio, D.A.2    Sander, S.D.3
  • 10
    • 33947277849 scopus 로고    scopus 로고
    • The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden
    • Björholt I, Andersson S, Nilsson GH et al. The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden. BMC Fam Pract. 2007; 8:6-13.
    • (2007) BMC Fam Pract , vol.8 , pp. 6-13
    • Björholt, I.1    Andersson, S.2    Nilsson, G.H.3
  • 11
    • 14044279786 scopus 로고    scopus 로고
    • Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: A multi-site managed-care study
    • DOI 10.1345/aph.1E169
    • Menzin J, Boulanger L, Hauch O et al. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinical settings: a multi-site managed-care study. Ann Pharmacother. 2005; 39:446-51. (Pubitemid 40276873)
    • (2005) Annals of Pharmacotherapy , vol.39 , Issue.3 , pp. 446-451
    • Menzin, J.1    Boulanger, L.2    Hauch, O.3    Friedman, M.4    Marple, C.B.5    Wygant, G.6    Hurley, J.S.7    Pezzella, S.8    Kaatz, S.9
  • 12
    • 77049099324 scopus 로고    scopus 로고
    • Potentially avoidable inpatient nights among warfarin receiving patients; an audit of a single university teaching hospital
    • Forde D, O'Connor MB, Gilligan O. Potentially avoidable inpatient nights among warfarin receiving patients; an audit of a single university teaching hospital. BMC Res Notes. 2009; 2:41-5.
    • (2009) BMC Res Notes , vol.2 , pp. 41-45
    • Forde, D.1    O'Connor, M.B.2    Gilligan, O.3
  • 13
    • 79451472118 scopus 로고    scopus 로고
    • Cost efficiency of anticoagulation with warfarin to prevent stroke in Medicare beneficiaries with nonvalvular atrial fibrillation
    • Mercaldi CJ, Ciarametaro M, Hahn B et al. Cost efficiency of anticoagulation with warfarin to prevent stroke in Medicare beneficiaries with nonvalvular atrial fibrillation. Stroke. 2011; 42:112-8.
    • (2011) Stroke , vol.42 , pp. 112-118
    • Mercaldi, C.J.1    Ciarametaro, M.2    Hahn, B.3
  • 15
    • 33744482871 scopus 로고    scopus 로고
    • Joint Commission. (accessed 2011 Apr 7)
    • Joint Commission. 2010 National Patient Safety Goals. www.jcrinc.com/Joint-Commission-Requirements/Hospitals/ (accessed 2011 Apr 7).
    • (2010) National Patient Safety Goals
  • 17
    • 0034946345 scopus 로고    scopus 로고
    • The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed
    • DOI 10.1053/jhin.2000.0881
    • Plowman R, Graves N, Griffin MA et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect. 2001; 47:198-209. (Pubitemid 32631848)
    • (2001) Journal of Hospital Infection , vol.47 , Issue.3 , pp. 198-209
    • Plowman, R.1    Graves, N.2    Griffin, M.A.S.3    Roberts, J.A.4    Swan, A.V.5    Cookson, B.6    Taylor, L.7
  • 18
    • 77949910338 scopus 로고    scopus 로고
    • Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia
    • Eber MR, Laxminarayan R, Perencevich EN et al. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Intern Med. 2010; 170:347-53.
    • (2010) Arch Intern Med , vol.170 , pp. 347-353
    • Eber, M.R.1    Laxminarayan, R.2    Perencevich, E.N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.